Teaching NeuroImage: Cerebral Amyloid Angiopathy–Related Inflammation
An Interesting Evolution of Imaging Findings
Citation Manager Formats
Make Comment
See Comments

A 77-year-old previously well woman presented with confusion, visual hallucinations, and signs of parietal lobe dysfunction, preceded by 5 days of headache. MRI of the brain demonstrated diffuse sulcal fluid-attenuated inversion recovery hyperintensities (Figure, A) and subtle leptomeningeal enhancement. Susceptibility-weighted imaging (SWI) was normal (Figure, B). Neurosurgical biopsy-confirmed cerebral amyloid angiopathy with perivascular inflammation (Figure, D–F). Pulsed methylprednisolone was given with excellent clinical response. MRI 7 weeks post symptom onset demonstrated widespread microhaemorrhages (Figure, C).
(A) Fluid-attenuated inversion recovery sequence shows extensive sulcal hyperintensity. (B) Normal SWI MIP. (C) SWI MIP shows multiple peripheral microhaemorrhages. (D) Aneurysmal meningeal vessel, occluded by recanalising thrombus with extensive perivascular lymphocytic infiltration. (E) Parallel section of cortex with meninges, brown staining indicates accumulated beta-A4. (F) Meningeal and parenchymal vascular beta-A4 immunoreactivity. Plaques also evident. MIP = minimum intensity projection; SWI = susceptibility-weighted imaging.
In the largest prospective study, all patients had abnormal SWI at presentation.1 Normal SWI at presentation can rarely occur in CAA-ri; therefore, clinical suspicion is important.2
Study Funding
No targeted funding reported.
Disclosure
The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Roy Strowd III, MD, MEd, MS.
Teaching slides links.lww.com/WNL/C81
- Received January 7, 2022.
- Accepted in final form April 22, 2022.
- © 2022 American Academy of Neurology
References
- 1.↵
- Antolini L,
- DiFrancesco JC,
- Zedde M, et al
- 2.↵
- Aghetti A,
- Sène D,
- Polivka M, et al
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.